Four Mexican pharmaceutical companies have announced plans to invest more than 13 billion pesos in drug development and ...

In this Q&A, Dean discusses how RXO is helping brands optimize performance and build more resilient supply chains through technology and data-driven strategy.

The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient ...

Industry 5.0 is all about advancing industrial systems to the next stage of maturity—a stage that unifies the creativity of ...

In this month's issue of Supply Chain Management Review, we look at what lessons supply chain leaders can take from Olympic ...

While consumer brands have long mastered the art of tailoring experiences, B2B players are now facing rising expectations ...

In the second part of this roundtable discussion, a panel of key opinion leaders dive into the key risk factors impacting the pharma manufacturing space, and how the industry should aim to address ...

Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said in ...